跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PIPERACILLIN AND TAZOBACTAM FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Authorized
STANDARD
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e5be4895d147606a
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
e5be4895d147606a
Drug Approval Canada Name
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Product Name
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Status
Marketed
Status Date
2022-04-29
Original Market Date
2022-04-29
Din
02521539
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:12.16.16
Atc Original
J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR
Atc Name
j 01 cr 05
Aig Number
0225919008
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
TAZOBACTAM (TAZOBACTAM SODIUM)
4.5 G / VIAL
PIPERACILLIN (PIPERACILLIN SODIUM)
36 G / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e5be4895d147606a
Type
Standard
Back to Health Canada Approvals